Freestone Grove Partners’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,807
Closed -$364K 690
2024
Q4
$364K Buy
+6,807
New +$364K ﹤0.01% 432